REG - STV Group PLC - Appointment of Joint Corporate Brokers

STVAnnouncement

Thu 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251211:nRSK0925La&default-theme=true

RNS Number : 0925L  STV Group PLC  11 December 2025

 

STV Group plc

 

11 December 2025

 

LEI: 21380075GOOTTBDNDJ58

Appointment of Joint Corporate Brokers

STV Group plc is pleased to announce the appointments of Singer Capital
Markets and Cavendish Capital Markets as the Company's Joint Corporate Brokers
effective immediately.

Ends

 

 Enquiries:
 STV Group plc:
 Kirstin Stevenson, Head of Communications                                        kirstin.stevenson@stv.tv  Tel: 07803 970106
 Singer Capital Markets:
 Charles Leigh-Pemberton / Sara Hale / James Fischer                                                        Tel: 020 7496 3000
 Cavendish Capital Markets:
 Matt Goode (Corporate Finance)                                                                             Tel: 020 7220 0500

 Matt Lewis / Sunila da Silva (Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPUROWRVAUUAAA



            Copyright 2019 Regulatory News Service, all rights reserved